Federal Vaccine Guidance Stalled

CDC vaccine recommendations stall as federal policy overhaul faces legal challenges.

The FDA has approved mFlusiva, an mRNA flu vaccine that tested well in older adults, but the CDC has not issued guidance on its use, illustrating a broader breakdown in federal vaccine recommendations. Health Secretary Robert F. Kennedy Jr.’s overhaul of the Advisory Committee on Immunization Practices, which had guided CDC policy for decades, was challenged in court; a judge halted the replacement panel and suspended efforts to reduce recommended childhood vaccines, but the ruling did not restore the previous process. As a result, guidance on new vaccines has stalled and public forums for weighing vaccine policy questions have diminished. Medical groups welcomed the court ruling, while experts warned that the disruption and weakened trust in the administration’s vaccine recommendations could leave doctors and the public without a clear, evidence-based path for decisions.

Key Points

Topics